Becton Dickinson (BDX) Tops Q1 EPS by 2c, Revenues Beat; Lowers FY20 EPS Guidance Below Consensus
Get Alerts BDX Hot Sheet
Revenue Growth %: +5.0%
Financial Fact:
Operating Income: 96M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Becton Dickinson (NYSE: BDX) reported Q1 EPS of $2.65, $0.02 better than the analyst estimate of $2.63. Revenue for the quarter came in at $4.23 billion versus the consensus estimate of $4.18 billion.
"In the first quarter, the BD team delivered solid results, in line with our expectations," said Tom Polen, CEO and president. "As we look ahead to the balance of the fiscal year, we are focused on the resolution of the Alaris pump matter. We stand behind the safety of the Alaris System, which is used in the care of 70 percent of patients undergoing infusion therapy. Now, we need to take the necessary steps to meet the FDA\'s expectations with respect to the Alaris System. We are committed to doing what is right for customers, patients and shareholders. You can expect that our purpose and values will always be at the core of who we are and how we work to resolve this situation moving forward."
GUIDANCE:
Becton Dickinson sees FY2020 EPS of $11.90-$12.10, versus the consensus of $12.56.
The company is lowering its full fiscal year 2020 revenue and adjusted diluted earnings per share guidance to reflect the impact of the remediation effort and anticipated loss of sales of the Alaris infusion system.
The company now expects full fiscal year 2020 revenues to increase 1.5 to 2.5 percent as reported, or 2.5 to 3.5 percent on a currency-neutral basis.
The company now expects full fiscal year 2020 adjusted diluted earnings per share to be between $11.90 and $12.10. This represents growth of approximately 4.0 to 5.5 percent on a currency-neutral basis over fiscal 2019 adjusted diluted earnings per share of $11.68, or growth of approximately 2.0 to 3.5 percent including the estimated unfavorable impact of foreign currency. Adjusted diluted earnings per share guidance includes an adverse impact of approximately 500 basis points related to the expiration of the Gore royalty.
For earnings history and earnings-related data on Becton Dickinson (BDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FI) Tops Q1 EPS by 9c; Boosts outlook
- Pentair (PNR) Tops Q1 EPS by 4c, Misses on Revenue; Offers FY24 EPS Guidance
- UPS (UPS) Tops Q1 EPS by 12c; Reaffirms Guidance
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Hot GuidanceRelated Entities
Earnings, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!